the african sleeping sickness

The post describes the parasite's unique immune evasion strategy, the cyclical nature of infection, and a specific approach to treatment using mechanism-based enzyme inhibitors, particularly focusing on the development and effectiveness of the drug difluoromethylornithine (DFMO) in combating the disease.